Altered gut microbiome populations may cause blood infections in paediatric cancer patients
Scientists discover that altered gut microbiome populations appear to influence the onset of blood infections in paediatric cancer patients.
List view / Grid view
Scientists discover that altered gut microbiome populations appear to influence the onset of blood infections in paediatric cancer patients.
Describing how a single nuclear stain can enable phenotypic profiling for new and additional perspectives on assays at no extra cost.
Water immersion lenses provide: brighter images from HCS samples; faster and gentler imaging; higher quality images from both 2D and 3D samples.
Researchers have developed a single blood test that screens for eight common cancer types and helps identify the location of cancer...
Researchers have demonstrated how a pixelated gene expression tool can accurately measure RNA levels more quickly than existing methods allow.
Researchers have outlined a pioneering method of screening a person’s diverse set of antibodies for rapid therapeutic discovery.
This year, BMG LABTECH’s Australian office celebrates 20 years of innovation and steady growth. The office was established in January 1998 to support Australia and the APAC region, offering excellent sales and customer service for BMG LABTECH’s wide range of dedicated and multi-mode microplate readers.
15 January 2018 | By BMG Labtech GmbH
Optimising the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems.Despite this, the kinetics of new receptor ligands are rarely measured early in the drug discovery process, largely because current assays are…
In this application note, PerkinElmer demonstrates the ease and utility of the AlphaScreen® cAMP assay for detecting both agonist and antagonist-induced cAMP responses within cells.
5 January 2018 | By PerkinElmer
LANCE (Lanthanide chelate excite) is a TR-FRET (time-resolved fluorescence resonance energy transfer), homogenous, no wash technology.
In this application note, PerkinElmer demonstrates how LANCE® Ultra, a homogeneous assay format, can be used to quickly and accurately assess modulation of pSTAT3.
4 January 2018 | By IntelliCyt Corporation
In this webinar, speakers discussed how the IntelliCyt iQue Screener Plus platform is being utilised to deliver rich datasets for compound screening, target validation and is how it is transforming immuno-oncology.
In this application note, PerkinElmer demonstrates the ease and utility of using LANCE® Ultra, a homogeneous assay format, for determining binding profiles of therapeutic monoclonal antibodies to FcγRs.
In this application note, PerkinElmer demonstrates the sensitivity, robust performance, and HTS suitability of the LANCE Ultra cytokine biomarker kits.